Epichem Supporting Brain Cancer Research Teams Applying for the MRFF Australian Brain Cancer Mission 2025
James Rixson
Epichem Supporting Brain Cancer Research Teams Applying for the MRFF Australian Brain Cancer Mission 2025
The Medical Research Future Fund (MRFF) has opened the Australian Brain Cancer Mission – 2025 Brain Cancer Research Grant Opportunity, offering up to $4.75 million to support innovative research projects that reduce treatment toxicity and improve quality of life for people affected by brain cancer. Each successful project may receive up to $2.0 million, with applications closing 4 February 2026.
If your project involves small molecule drug discovery, medicinal chemistry, translational oncology, or chemistry-driven innovation in brain cancer research, Epichem can help strengthen your proposal and deliver high-quality chemistry support aligned to the Mission’s objectives.
How Epichem Can Support Your Brain Cancer Mission Application
As Australia’s leading provider of medicinal and synthetic chemistry services, Epichem can partner with research teams, universities, SMEs and biotech innovators to deliver critical chemistry work packages that enhance competitiveness and technical merit.
We can support your application with:
Hit-to-lead and lead optimisation chemistry to advance novel therapeutic candidates
Custom synthesis and scalable route development for tool compounds, intermediates and preclinical analogues
Analytical chemistry, characterisation and reference material generation
Medicinal chemistry strategy support (SAR design and prioritisation)
Clear, realistic work scopes and scoping cost estimates for grant applications
Our team can help you define work packages, timelines and budgets that align with the grant guidelines — ensuring your proposal is technically sound and competitive. All work can be delivered from our Perth laboratories under a formal collaboration or subcontract arrangement.
About the MRFF Australian Brain Cancer Mission 2025 Grant
The Australian Brain Cancer Mission is a national initiative to support innovative research that improves outcomes for people living with brain cancer. The 2025 grant opportunity focuses on projects that:
Develop novel approaches to reduce treatment toxicity and adverse effects
Minimise the short- and long-term burden of brain cancer treatment on patients and carers
Improve quality of life and wellbeing for Australians affected by brain cancer
Applications opened in September 2025, with the minimum data deadline on 21 January 2026 and final applications due by 4 February 2026. Funding of up to $2 million per project is available, with the total pool for this round around $4.75 million.
Work With Epichem
Whether your brain cancer research team is seeking medicinal chemistry expertise, synthesised compounds, analytical insights, or partner scoping support, Epichem is ready to collaborate.
Get in touch to discuss how we can help tailor chemistry work packages that enhance your MRFF Australian Brain Cancer Mission proposal — and bring your science closer to real patient impact.
